Evidence generation expert with deep experience in policy-facing research and market launch and market shifts strategy. Leads multi-disciplinary teams to design studies that generate insights and address uncertainty across the product lifecycle. Specializes in aligning evidence plans with market and policy needs, with expertise spanning rare diseases, oncology, infectious diseases, neurology, and psychiatry.